NCT Number,Study Title,Brief Summary,Conditions,Interventions,Adjuvant Name
NCT01479244,Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence,"Purpose of this trial:

1. To assess the efficacy and safety of NeuVax™ administered with adjuvant Leukine® (sargramostim, GM-CSF).
2. To evaluate and compare the disease free survival (DFS) in the vaccinated and control subjects.",Breast Cancer With Low to Intermediate HER2 Expression,"BIOLOGICAL: NeuVax™ vaccine|BIOLOGICAL: Leukine® (sargramostim, GM-CSF) and water for injection",GM-CSF
